Clinical trial
The Effect of Bevacizumab on Corneal Neovascularization
NCT00797303 is registered in ClinicalTrials.gov with Instituto de Olhos de Goiania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Bevacizumab on Corneal Neovascularization
- Lead sponsor
- Instituto de Olhos de Goiania
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 31, 2006
- Completion date
- November 30, 2008
- Enrollment
- 8 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.